Cytomel

Cytomel is a brand name of liothyronine, approved by the FDA in the following formulation(s):

CYTOMEL (liothyronine sodium - tablet; oral)

• 
  Manufacturer: KING PHARMS
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 0.005MG BASE ^[AB], EQ 0.025MG BASE ^[AB], EQ 0.05MG BASE ^[RLD][AB]

Has a generic version of Cytomel been approved?

Yes. The following products are equivalent to Cytomel:

liothyronine sodium tablet; oral

• 
  Manufacturer: COASTAL PHARMS
  
  Approval date: March 20, 2009
  
  Strength(s): EQ 0.005MG BASE ^[AB], EQ 0.025MG BASE ^[AB], EQ 0.05MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: July 14, 2009
  
  Strength(s): EQ 0.005MG BASE ^[AB], EQ 0.025MG BASE ^[AB], EQ 0.05MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Cytomel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Cytomel.

See also...

• Cytomel Consumer Information (Wolters Kluwer)
• Cytomel Consumer Information (Cerner Multum)
• Cytomel Advanced Consumer Information (Micromedex)
• Liothyronine Consumer Information (Wolters Kluwer)
• Liothyronine Tablets Consumer Information (Wolters Kluwer)
• Liothyronine Consumer Information (Cerner Multum)
• Liothyronine Advanced Consumer Information (Micromedex)
• Liothyronine Intravenous Advanced Consumer Information (Micromedex)
• Liothyronine Sodium AHFS DI Monographs (ASHP)